Shi, Y., Tang, X., Wu, L., Guo, W., Hu, Y., Wang, H., Xie, S., Li, Q., Yao, Y., Wang, Y. (2026). A randomized, open-label, parallel-controlled phase 3 trial of benmelstobart plus chemotherapy and anlotinib for first-line treatment of advanced non-squamous non–small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.17_suppl.lba8507